首页    期刊浏览 2024年11月30日 星期六
登录注册

文章基本信息

  • 标题:Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials
  • 本地全文:下载
  • 作者:Musha Chen ; Yue Yuan ; Yiguo Zhou
  • 期刊名称:Infectious Diseases of Poverty
  • 印刷版ISSN:2049-9957
  • 出版年度:2021
  • 卷号:10
  • 期号:1
  • 页码:1-12
  • DOI:10.1186/s40249-021-00878-5
  • 出版社:BioMed Central
  • 摘要:Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data search was performed in PubMed, Embase, Cochrane library, Scopus, Web of Science, and MedRxiv. Included articles were limited to RCTs on COVID-19 vaccines. A total of 73,633 subjects from 14 articles were included to compare the risks of adverse events following immunization (AEFI) after vaccinating different COVID-19 vaccines. Pooled risk ratios (RR) of total AEFI for inactivated vaccine, viral-vectored vaccine, and mRNA vaccine were 1.34 [95% confidence interval (CI) 1.11–1.61, P < 0.001], 1.65 (95% CI 1.31–2.07, P < 0.001), and 2.01 (95% CI 1.78–2.26, P < 0.001), respectively. No significant differences on local and systemic AEFI were found between the first dose and second dose. In addition, people aged ≤ 55 years were at significantly higher risk of AEFI than people aged ≥ 56 years, with a pooled RR of 1.25 (95% CI 1.15–1.35, P < 0.001). The safety and tolerance of current COVID-19 vaccine candidates are acceptable for mass vaccination, with inactivated COVID-19 vaccines candidates having the lowest reported AEFI. Long-term surveillance of vaccine safety is required, especially among elderly people with underlying medical conditions.
  • 关键词:COVID-19 vaccine ; Safety ; Adverse events following immunization ; Randomized controlled trial ; Meta-analysis
国家哲学社会科学文献中心版权所有